- Published at
- by manilatimes.net
positive
positive
News for ProPhase Labs, Inc. (PRPH)
- Published at
- by gurufocus.com
positivepositiveProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs
Company Announces Ongoing Strategic Cost Cutting to Focus Resources on new DTC Marketing Initiatives to Drive Growth and Profitability Dispels rumors of an Inv- Published at
- by seekingalpha.com
positivepositiveProPhase Labs shares rise on cost cutting plans, hires former Barstool Sports COO Stu Hollenshead
ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measures- Published at
- by gurufocus.com
positivepositiveProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports
GARDEN CITY, NY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. ( PRPH) (”ProPhase” or the ”Company”), a next-generation biotech, genomics, and- Published at
- by investing.com
positivepositiveProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles By Investing.com
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles- Published at
- by manilatimes.net
positivepositive- Published at
- by investing.com
neutralneutralProPhase Labs stock hits 52-week low at $0.61 amid sharp decline By Investing.com
ProPhase Labs stock hits 52-week low at $0.61 amid sharp decline- Published at
- by gurufocus.com
positivepositiveProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures
The Company will review on Thursday, December 12th, at 12:00 p.m. EST. GARDEN CITY, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. ( PRPH) (”Pro- Published at
- by gurufocus.com
neutralneutralProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial Maneuvers Amidst Cash Flow Challenges
Capital Raise: Executed to support aggressive launch of DNA Complete and DNA Expand, and to address cash flow imbalance due to delayed customer payments.Expens- Published at
- by gurufocus.com
positivepositiveQ3 2024 Prophase Labs Inc Earnings Call Transcript
Nov 13, 2024 / 04:00PM GMTNoella Alexander Young - Renmark Financial communications - virtual event moderator Hello and good morning, everyone. Welcome to today- Published at
- by insidermonkey.com
positivepositiveProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript
Noella Alexander-Young: Hello, and good morning, everyone. Welcome to today's presentation. My name is Noella Alexander-Young, the virtual event moderator here at Redmark Financial Communications.- Published at
- by seekingalpha.com
positivepositiveProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Results Conference Call November 13, 2024 11:00 AM ETCompany ParticipantsNoella Alexander-Young - Renmark...- Published at
- by manilatimes.net
mixedmixed- Published at
- by zacks.com
positivepositiveProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates
ProPhase Labs (PRPH) delivered earnings and revenue surprises of -12.90% and 11.56%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by investing.com
mixedmixedU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%- Published at
- by benzinga.com
mixedmixedWhy Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Upstart Hldgs (NASDAQ:UPST)
Shares of Upstart Holdings, Inc. UPST rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial results...- Published at
- by gurufocus.com
mixedmixedGuardant Health (GH) Shares Decline Amid Market Volatility
Guardant Health, Inc. (GH), a prominent player in the liquid biopsy field, experienced a significant share price drop of 5.00%. Currently trading at $20.54 with- Published at
- by globenewswire.com
positivepositiveProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create...- Published at
- by seekingalpha.com
mixedmixedRare Stock Picks In May 2024 - From 29 Discerning Analysts
In our monthly Rare Stock Picks series, we're highlighting May 2024 investment picks. Click here for the list of May 2024 Buy recommendations.VIVT3.SAVIV1N.MXVIV.BAVIVUMCTROWT1RO34.SARTPPFRTNTFRIOD.BARIO1.DERIO.LRIO.AXRIOORCL.MXORCL.BAORCLORC.DENFLXD.BANFLX34.SANFLX.MXNFLX.BANFLXNFC.DEKRO.JOKMI.MXKMIKAROHLMNFTNT.MXFTNTFOXFEOLSDEEC34.SADE.MXDE.BADEDCO.DEDBX.MXDBXCEIXCARBN.OLBDNASNDASAI3.SAASAI-WIASAIACNN.MXACNA1SN34.SA2KD.DE2303.TW1Q5.DE0Y0Y.L0SGO.L0R2P.L0KWZ.L0KNY.L0K16.L0JR2.L0IR9.LPRPHKOFUBL.MXKOFDISCA.MXDCVY35.SACOCSFCELH0IBF.L0IBD.L- Published at
- by globenewswire.com
positivepositiveProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
Commercialization of Equivir anticipated after second trial is completed in Q2, 2024 Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs,...